Bibliography
- Paternoster L, Standl M, Chen CM, Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis. Nat Genet 2011;44:187-92
- Miller DW, Koch SB, Yentzer BA, An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial. J Drugs Dermatol 2011;10:531-7
- Ong PY. Emerging drugs for atopic dermatitis. Expert Opin Emerg Drugs 2009;14:165-79
- Irvine AD, Mclean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011;365:1315-27
- Miajlovic H, Fallon PG, Irvine AD, Foster TJ. Effect of filaggrin breakdown products on growth of and protein expression by staphylococcus aureus. J Allergy Clin Immunol 2010;126:1184-1190; e3
- Stander S, Siepmann D, Herrgott I, Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS One 2010;5:e10968
- Ong PY, Ohtake T, Brandt C, Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-60
- Huang JT, Rademaker A, Paller AS. Dilute bleach baths for staphylococcus aureus colonization in atopic dermatitis to decrease disease severity. Arch Dermatol 2011;147:246-7
- Wolk K, Kunz S, Witte E, IL-22 increases the innate immunity of tissues. Immunity 2004;21:241-54
- Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol 2008;181:7420-7
- Nograles KE, Zaba LC, Shemer A, IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 2009;123:1244-52; e2
- Sonnenberg GF, Nair MG, Kirn TJ, Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J Exp Med 2010;207:1293-305
- Miller LS, Cho JS. Immunity against staphylococcus aureus cutaneous infections. Nat Rev Immunol 2011;11:505-18
- Niebuhr M, Heratizadeh A, Wichmann K, Intrinsic alterations of pro-inflammatory mediators in unstimulated and TLR-2 stimulated keratinocytes from atopic dermatitis patients. Exp Dermatol 2011;20(6):468-72
- Schroder JM. The role of keratinocytes in defense against infection. Curr Opin Infect Dis 2010;23:106-10
- Jansen PA, Rodijk-Olthuis D, Hollox EJ, Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin. PLoS One 2009;4:e4725
- Midorikawa K, Ouhara K, Komatsuzawa H, Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun 2003;71:3730-9
- Schlievert PM, Strandberg KL, Lin YC, Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol 2010;125:39-49
- Travers JB, Kozman A, Yao Y, Treatment outcomes of secondarily impetiginized pediatric atopic dermatitis lesions and the role of oral antibiotics. Pediatr Dermatol 2011; [Epub ahead of print]
- Niebuhr M, Mamerow D, Heratizadeh A, Staphylococcal alpha-toxin induces a higher T cell proliferation and interleukin-31 in atopic dermatitis. Int Arch Allergy Immunol 2011;156:412-15